Company profile: VivaBioCell
1.1 - Company Overview
Company description
- Provider of innovative products leveraging proprietary cell culture and tissue engineering technologies for early diagnosis of autoimmune diseases (e.g., scleroderma, graft-versus-host disease) and treatment of oro-dental and maxillo-facial defects.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VivaBioCell
Navamedic
HQ: Sweden
Website
- Description: Provider of pharmaceutical and medtech products, marketing to patients, hospitals and pharmacies. Offers prescription and OTC medicines and healthcare products; the Sippi next-generation digital urine meter; and a portfolio including Eroxon gel to help men achieve an erection, Flexilev for Parkinson’s, Absolut Torr antiperspirant, MedMade micronutrient supplements, and PKU and obesity education/support programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navamedic company profile →
Labopharm
HQ: Canada
Website
- Description: Provider of specialty pharmaceutical solutions that optimize the performance of existing drugs using advanced controlled-release technologies; operates internationally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labopharm company profile →
Insys Therapeutics
HQ: United States
Website
- Description: Provider of specialty pharmaceuticals, developing and commercializing innovative supportive care products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Insys Therapeutics company profile →
Lewis and Clark Pharmaceuticals
HQ: United States
Website
- Description: Provider of early-stage pharmaceutical development targeting treatments for arthritis, diabetes, glaucoma, and atherosclerosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lewis and Clark Pharmaceuticals company profile →
Synaptogenix
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies in development for neurodegenerative diseases, using bryostatin to promote neuronal health and synaptic regeneration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synaptogenix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VivaBioCell
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VivaBioCell
2.2 - Growth funds investing in similar companies to VivaBioCell
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VivaBioCell
4.2 - Public trading comparable groups for VivaBioCell
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →